Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis Almirall gets in on the eczema action Richard Staines Almirall, atomic dermatitis, Dupixent, eczema, LEO Pharma, Sanofi 0 Comment Sanofi’s Dupixent has shown there is a market for biologic drugs to treat eczema, and now Spain’s Almirall Share X Almirall gets in on the eczema action https://pharmaphorum.com/views-analysis-market-access/almirall-gets-in-on-the-eczema-action/
Almirall, atomic dermatitis, Dupixent, eczema, LEO Pharma, Sanofi
0 Comment
